Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GXCPC1
- Development stage
- Phase 2
- Lead developer
- Gwo Xi Stem Cell Applied Technology
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraarticular
01
Overview
GXCPC1 is an allogeneic adipose-derived mesenchymal stem cell (ADSC) therapy developed by Gwo Xi Stem Cell Applied Technology. It is currently under clinical investigation for the treatment of knee osteoarthritis. The therapy involves the intra-articular injection of stem cells harvested from healthy donors, which are processed and expanded to therapeutic quantities. These cells are intended to function through paracrine signaling, releasing a variety of growth factors and anti-inflammatory cytokines that modulate the local immune environment and promote the repair of damaged articular cartilage. By addressing the underlying inflammatory and degenerative processes, GXCPC1 aims to alleviate pain and improve joint function in patients with osteoarthritis.
- Other names
- allogeneic adipose-derived stem cellsallogeneic ADSCs
Beyond the preview
Go deeper on GXCPC1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GXCPC1.